Exact Sciences to Participate in May Investor Conference

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

  • BofA Securities Health Care Conference, Las Vegas

    Fireside chat on Wednesday, May 15, 2024 at 4:40 p.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.20
+5.72 (2.64%)
AAPL  263.80
+1.56 (0.59%)
AMD  239.54
-1.02 (-0.42%)
BAC  51.93
-0.11 (-0.21%)
GOOG  248.89
-8.13 (-3.16%)
META  732.44
+0.27 (0.04%)
MSFT  515.82
-0.97 (-0.19%)
NVDA  182.33
-0.31 (-0.17%)
ORCL  279.44
+2.26 (0.82%)
TSLA  447.93
+0.50 (0.11%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.